RedHill Biopharma Ltd.

For the period ended Dec 31, 2025. Filed Apr 27, 2026.

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2025 · Filed Apr 27, 2026

RDHL$0.43+0.4%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Cover page Table of Contents

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS (no text here)

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE (no text here)

ITEM 3. KEY INFORMATION ITEM 4. INFORMATION ON THE COMPANY

ITEM 4A. UNRESOLVED STAFF COMMENTS (no text here)

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS ITEM 8. FINANCIAL INFORMATION ITEM 9. THE OFFER AND LISTING ITEM 10. ADDITIONAL INFORMATION ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES (no text here)

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS (no text here)

ITEM 15. CONTROLS AND PROCEDURES

ITEM 16. [RESERVED] (no text here)

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT ITEM 16B. CODE OF ETHICS ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES (no text here)

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS (no text here)

ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT (no text here)

ITEM 16G. CORPORATE GOVERNANCE

ITEM 16H. MINE SAFETY DISCLOSURE (no text here)

ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS (no text here)

ITEM 16J. INSIDER TRADING POLICIES ITEM 16K. CYBERSECURITY

ITEM 17. FINANCIAL STATEMENTS (no text here)

ITEM 18. FINANCIAL STATEMENTS ITEM 19. EXHIBITS GLOSSARY OF TERMS EXHIBIT INDEX SIGNATURES Report of Independent Registered Public Accounting Firm Consolidated Statements of Comprehensive Income (Loss Consolidated Statements of Financial Position Consolidated Statements of Changes in Equity (Capital Deficiency)Item 8. Consolidated Statements of Cash Flows Notes to the Consolidated Financial Statements

ITEM 16B. CODE OF ETHICS

As of the date of this Annual Report, we have adopted a code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. This code of ethics is posted on our website, https://s28.q4cdn.com/226515471/files/doc_downloads/gov_docs/Standards-of-Business-Conduct-and-Ethics.pdf. We intend to post on our website any amendments or waivers to the code of ethics that apply to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.